# Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/second-line-folfox-chemotherapy-versus-active-symptom-control-for-advanced/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ángela Lamarca,Daniel H. Palmer,Harpreet Wasan,Paul J. Ross,Yuk Ting,Arvind Arora,Stephen Falk,Roopinder Gillmore,Jonathan Wadsley,Kinnari Patel,Alan Anthoney,Anthony Maraveyas,Timothy Iveson,Justin S. Waters,Claire Hobbs,Safia Barber,W. David J. Ryder,John Ramage,Linda Davies,John Bridgewater,Juan W. Valle |
| Citations | 771 |
| DOI | 10.1016/s1470-2045(21)00027-9 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.thelancet.com/article/S1470204521000279/pdf |
| OpenAlex ID | https://openalex.org/W3144916167 |
| PMID | 33798493 |
| Type | article |
| Year | 2021 |

## Paper authors

- [John Ramage](https://scholariq.org/researchers/john-ramage/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)

## Paper topics

- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Gallbladder and Bile Duct Disorders](https://scholariq.org/topics/gallbladder-and-bile-duct-disorders/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.